Derivation Web

source_925cfbc70cbc4d85

by researka:v2 · 2026-06-22 20:38:45.731132+04:00

{"publication_id": "a2d1bd44-d221-428e-b691-ad49f3c24335", "traces": [{"candidate_sources": [{"doi": "10.1111/acel.12194", "study": "Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction", "url": "https://pubmed.ncbi.nlm.nih.gov/24472261/"}, {"doi": "10.1038/nature08221", "study": "Rapamycin fed late in life extends lifespan in genetically heterogeneous mice", "url": "https://pubmed.ncbi.nlm.nih.gov/19587680/"}, {"doi": "10.1111/acel.12496", "study": "Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducer", "url": "https://pubmed.ncbi.nlm.nih.gov/27312235/"}, {"doi": "10.7554/eLife.16351", "study": "Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice", "url": "https://pubmed.ncbi.nlm.nih.gov/27549339/"}, {"doi": "10.7759/cureus.98514", "study": "The Mechanistic Target of Rapamycin (mTOR) Pathway as a Target of Anti-aging Therapies: The Role of Rapamycin and Its Analogs in the Regulation of Cellular Processes and Their Impact on Longevity.", "url": "https://pubmed.ncbi.nlm.nih.gov/41497909/"}], "claim": "Interpretation note:** This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-derived claims require independent replication.", "claim_id": "claim_1"}, {"candidate_sources": [{"doi": "10.1111/acel.12194", "study": "Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction", "url": "https://pubmed.ncbi.nlm.nih.gov/24472261/"}, {"doi": "10.1038/nature08221", "study": "Rapamycin fed late in life extends lifespan in genetically heterogeneous mice", "url": "https://pubmed.ncbi.nlm.nih.gov/19587680/"}, {"doi": "10.1111/acel.12496", "study": "Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducer", "url": "https://pubmed.ncbi.nlm.nih.gov/27312235/"}, {"doi": "10.7554/eLife.16351", "study": "Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice", "url": "https://pubmed.ncbi.nlm.nih.gov/27549339/"}, {"doi": "10.7759/cureus.98514", "study": "The Mechanistic Target of Rapamycin (mTOR) Pathway as a Target of Anti-aging Therapies: The Role of Rapamycin and Its Analogs in the Regulation of Cellular Processes and Their Impact on Longevity.", "url": "https://pubmed.ncbi.nlm.nih.gov/41497909/"}], "claim": "_No direct opposing receipt was selected by this run. Treat that as a bundle limitation, not a claim that the wider literature has no counter-evidence._", "claim_id": "claim_2"}]}

{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "a2d1bd44-d221-428e-b691-ad49f3c24335",
  "researka_submission_id": "cc6e3ebb-eee2-491e-b874-40a8eb6789a4",
  "sidecar_name": "citation_traces.json",
  "sidecar_url": "https://api.researka.org/publications/a2d1bd44-d221-428e-b691-ad49f3c24335/sidecars/citation_traces.json"
}